These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 25922539)

  • 1. Antithrombotic treatment and intracerebral haemorrhage: between Scylla and Charybdis.
    Hofmeijer J; Kappelle LJ; Klijn CJ
    Pract Neurol; 2015 Aug; 15(4):250-6. PubMed ID: 25922539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Resumption of antithrombotic treatment after an intracerebral haemorrhage].
    Kappelle LJ; Hofmeijer J; Chamuleau SA; van Nieuwenhuizen KM; Hemels ME; Klijn CJ
    Ned Tijdschr Geneeskd; 2015; 159():A8507. PubMed ID: 25873219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New horizons: managing antithrombotic dilemmas in patients with cerebral amyloid angiopathy.
    Kelly J
    Age Ageing; 2021 Feb; 50(2):347-355. PubMed ID: 33480964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cerebral amyloid angiopathy and atrial fibrillation: anticoagulant dilemma].
    Boutitie L; Verny M; Alamowitch S; Zerah L
    Geriatr Psychol Neuropsychiatr Vieil; 2023 Mar; 21(1):81-89. PubMed ID: 37115683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboprophylaxis in the oldest old with atrial fibrillation: between Scylla and Charybdis.
    Mannucci PM
    Eur J Intern Med; 2013 Jun; 24(4):285-7. PubMed ID: 23499350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracerebral haemorrhage, microbleeds and antithrombotic drugs.
    Casolla B; Cordonnier C
    Rev Neurol (Paris); 2021; 177(1-2):11-22. PubMed ID: 32747048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation in restarting antithrombotic drugs at hospital discharge after intracerebral hemorrhage.
    Pasquini M; Charidimou A; van Asch CJ; Baharoglu MI; Samarasekera N; Werring DJ; Klijn CJ; Roos YB; Al-Shahi Salman R; Cordonnier C
    Stroke; 2014 Sep; 45(9):2643-8. PubMed ID: 25082804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic therapy for stroke prevention in non-valvular atrial fibrillation.
    Alberts MJ; Eikelboom JW; Hankey GJ
    Lancet Neurol; 2012 Dec; 11(12):1066-81. PubMed ID: 23153406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: a global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation.
    Huisman MV; Lip GY; Diener HC; Dubner SJ; Halperin JL; Ma CS; Rothman KJ; Teutsch C; Zint K; Ackermann D; Clemens A; Bartels DB
    Am Heart J; 2014 Mar; 167(3):329-34. PubMed ID: 24576516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
    Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
    Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome after anticoagulation-associated intracerebral haemorrhage with or without restarting antithrombotic therapy.
    Gathier CS; Algra A; Rinkel GJ; van der Worp HB
    Cerebrovasc Dis; 2013; 36(1):33-7. PubMed ID: 23920426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic therapy in nonvalvular atrial fibrillation: a narrative review.
    Sá SP; Rodrigues RP; Santos-Antunes J; Rocha Gonçalves F; Nunes JP
    Rev Port Cardiol; 2011 Dec; 30(12):905-24. PubMed ID: 22094310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral antithrombotic therapy in atrial fibrillation associated with acute or chronic coronary artery disease.
    Cairns JA; McMurtry MS
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S60-70. PubMed ID: 23790600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intracerebral hemorrhage under platelet inhibition and oral anticoagulation in patients with cerebral amyloid angiopathy].
    Haußmann R; Homeyer P; Haußmann M; Brandt M; Donix M; Puetz V; Linn J
    Nervenarzt; 2022 Jun; 93(6):599-604. PubMed ID: 34652485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracerebral haemorrhage associated with antithrombotic treatment: translational insights from experimental studies.
    Lauer A; Pfeilschifter W; Schaffer CB; Lo EH; Foerch C
    Lancet Neurol; 2013 Apr; 12(4):394-405. PubMed ID: 23518332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischaemic stroke: acute-phase drug therapy. Mostly aspirin and heparin.
    Prescrire Int; 2005 Aug; 14(78):146-52. PubMed ID: 16106599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic Treatment Management in Patients with Intracerebral Hemorrhage: Reversal and Restart.
    Giakoumettis D; Alexiou GA; Vrachatis DA; Themistoklis K; Stathis P; Vavuranakis M; Themistocleous MS
    Curr Pharm Des; 2017; 23(9):1392-1405. PubMed ID: 27917716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic management of atrial fibrillation for stroke prevention in older people.
    Tong DC; Albers GW
    Clin Geriatr Med; 1999 Nov; 15(4):645-62. PubMed ID: 10499928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic Treatment Patterns in Patients with Newly Diagnosed Nonvalvular Atrial Fibrillation: The GLORIA-AF Registry, Phase II.
    Huisman MV; Rothman KJ; Paquette M; Teutsch C; Diener HC; Dubner SJ; Halperin JL; Ma C; Zint K; Elsaesser A; Bartels DB; Lip GY;
    Am J Med; 2015 Dec; 128(12):1306-13.e1. PubMed ID: 26239094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.